If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

Share Price is delayed by 15 minutes
Get Live Data
79.78    -0.32 (-0.40%)
Bid:
79.62
Ask:
79.66
Spread: 0.04 (0.05%)
Market Cap: £2.77b
TW. Live PriceLast checked at - London Stock Exchange

Intraday Taylor Wimpey Share Chart

Board Changes

20 Apr 2018 07:00

RNS Number : 5446L
Taylor Wimpey PLC
20 April 2018
 

 

 

20 April 2018

Taylor Wimpey plc

 

Change of Group Finance Director and Appointment of Group Operations Director to the Board of Taylor Wimpey plc

 

Taylor Wimpey plc announces that Ryan Mangold will be leaving his role as Group Finance Director after almost eight years in that position. Ryan will step down as a Director on 20 April 2018 but will continue to have an active role in the business until 31 December 2018, which will include helping to oversee the half year accounts and help to ensure an orderly transition. He will then be on garden leave until 19 April 2019.

Consistent with his contractual terms, Ryan will be paid salary and benefits in the normal way, will be considered for a bonus for the period of the FY18 actually worked by him and will be eligible to receive outstanding share awards, with long term incentive awards prorated and subject to previously set performance targets. Further details will be available on our website shortly.

Ryan will be succeeded by Chris Carney who will be appointed to the Board as Group Finance Director with effect from 20 April 2018. Chris is currently the Divisional Chairman of the Company's London and South East Division, a role he has held since 2015. Chris is a Chartered Accountant and having worked in both private practice and for Associated British Foods plc, joined Taylor Wimpey in 2006 as Group Financial Controller, a post he held until 2008. Chris then became the Finance Director of Taylor Wimpey UK (the Group's main operating company), before undertaking the role of Managing Director of the Company's South Thames business unit.

The Company is pleased to announce that Chris will be succeeded by Ingrid Osborne as the Divisional Chairman for the London and South East Division. Ingrid has significant operational and commercial experience and is currently the Divisional Managing Director of our Central and East London businesses. She is also a member of the Group Management Team.

The Company also announces the appointment of Jennie Daly to the Board as Group Operations Director with effect from 20 April 2018. Jennie joined Taylor Wimpey in 2014 from Redrow plc, as UK Planning Director, before becoming UK Land Director in 2015. She has a wealth of experience in the housebuilding industry gained from roles which include strategic land oversight at Westbury plc and managing director of Harrow Estates Plc. As Group Operations Director, Jennie oversees our land, planning, design and technical, production and supply chain functions, in addition to managing the Taylor Wimpey Logistics business. Jennie is also a non-executive director of the Peabody Trust.

Kevin Beeston, Chairman, said: "On behalf of the Board, I would like to express our sincere thanks to Ryan for his significant contribution to Taylor Wimpey as Group Finance Director over the past eight years and would like to wish him all the very best for the future.

I am also delighted to welcome both Chris Carney and Jennie Daly to the Board as Group Finance Director and Group Operations Director respectively. Both Chris and Jennie are existing members of the Group Management Team and each has a wealth of experience in the housebuilding industry, which will help to further strengthen the Board. I wish Chris and Jennie every success in their new roles. I would also like to wish Ingrid every success in her new role as Divisional Chairman of the London and South East Division. I am particularly pleased that the Board's active succession planning focus has produced such outstanding candidates, as well as helping to provide further opportunities in the business."

Ryan Mangold said: "I have thoroughly enjoyed my time at Taylor Wimpey having improved the strength and quality of the balance sheet and, as a member of the senior management team, driven a material improvement in business performance. I leave the Board with the business in a very strong financial position and I wish Taylor Wimpey continued success for the future."

The Company confirms that the business continues to trade in line with the Board's expectations and we look forward to updating shareholders further at our AGM on 26th April 2018.

There are no other details that require to be disclosed in respect of the appointment of Chris Carney or Jennie Daly to the Board of Taylor Wimpey plc pursuant to Rule 9.6.13 of the UK Listing Rules.

-Ends-

For further information please contact:

Taylor Wimpey plc Tel: +44 (0) 1494 558323

Pete Redfern, Chief ExecutiveJames Jordan, Group Legal Director and Company Secretary Debbie Archibald, Investor Relations

 

Finsbury Tel: +44 (0) 20 7251 3801

Faeth Birch

Anjali Unnikrishnan

 

Notes to editors:

Taylor Wimpey plc is a UK-focused residential developer, operating at a local level from 24 regional businesses across the UK. We also have operations in Spain.

For further information please visit the Group's website: www.taylorwimpey.co.uk/corporate

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAIMMMTMBTTMTP
Date   Source Headline
9th Dec 20254:18 pmRNSDirector Declaration
1st Dec 202512:03 pmRNSTotal Voting Rights
18th Nov 20253:47 pmRNSDirector/PDMR Shareholding
12th Nov 20257:00 amRNSTrading Statement
11th Nov 202512:07 pmRNSDirector/PDMR Shareholding
3rd Nov 20254:26 pmRNSTotal Voting Rights
17th Oct 20253:33 pmRNSPurchase of Shares by the Employee Benefit Trust
10th Oct 20259:27 amRNSDirector/PDMR Shareholding
1st Oct 202510:38 amRNSTotal Voting Rights
1st Oct 20257:00 amRNSInvestor and analyst update and trading statement
9th Sep 20254:18 pmRNSDirector/PDMR Shareholding
1st Sep 20258:00 amRNSTotal Voting Rights
11th Aug 20252:49 pmRNSDirector/PDMR Shareholding
1st Aug 202511:09 amRNSTotal Voting Rights
30th Jul 20257:00 amRNSHalf year results 2025
9th Jul 202512:43 pmRNSDirector/PDMR Shareholding
9th Jul 20258:05 amRNSCMA consults on proposed commitments
7th Jul 202512:43 pmRNSDirector Declaration
1st Jul 202511:32 amRNSBlock listing Interim Review
1st Jul 202511:30 amRNSBlock listing Interim Review
1st Jul 202511:10 amRNSTotal Voting Rights
23rd Jun 202510:34 amRNSHolding(s) in Company
10th Jun 20254:18 pmRNSDirector/PDMR Shareholding
2nd Jun 20251:28 pmRNSTotal Voting Rights
28th May 20254:27 pmRNSDirector/PDMR Shareholding
16th May 20258:55 amRNSHolding(s) in Company
15th May 20252:34 pmRNSDirector/PDMR Shareholding
13th May 20259:34 amRNSDirector/PDMR Shareholding
12th May 20251:24 pmRNSDirector/PDMR Shareholding
1st May 20253:51 pmRNSTotal Voting Rights
1st May 20259:22 amRNSHolding(s) in Company
30th Apr 20253:14 pmRNSResult of AGM
30th Apr 20257:00 amRNSTrading Statement
29th Apr 20254:26 pmRNSHolding(s) in Company
10th Apr 20254:36 pmRNSDirector/PDMR Shareholding
1st Apr 20253:48 pmRNSTotal Voting Rights
28th Mar 20252:20 pmRNSHolding(s) in Company
25th Mar 20252:47 pmRNSAnnual Financial Report and Notice of Meeting
25th Mar 20251:38 pmRNSDirector/PDMR Shareholding
25th Mar 202512:30 pmRNSHolding(s) in Company
24th Mar 20252:31 pmRNSHolding(s) in Company
14th Mar 20251:26 pmRNSHolding(s) in Company
12th Mar 20255:52 pmRNSHolding(s) in Company
12th Mar 20252:26 pmRNSHolding(s) in Company
11th Mar 20253:51 pmRNSDirector/PDMR Shareholding
6th Mar 20253:55 pmRNSHolding(s) in Company
6th Mar 20251:02 pmRNSDirector/PDMR Shareholding
6th Mar 20259:59 amRNSHolding(s) in Company
4th Mar 20255:15 pmRNSHolding(s) in Company
4th Mar 20251:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.